Schizophrenia Sensory Gating Deficit With Quetiapine
Completed
Conditions studied: Schizophrenia
In brief
The purpose of this study is the use of magnetoencephalography or MEG (a machine that measures magnetic activity in your brain) and electroencephalography or EEG (a technique that measures electrical activity in your brain) to study how sounds are processed in individuals with schizophrenia after three months of taking the antipsychotic medication quetiapine.
Key facts
- Study ID
- NCT00536783
- Run by
- New Mexico VA Healthcare System
- People needed
- 20
- Starts
- 2004-04-01
- Expected to finish
- 2006-03-01
- Last updated by the study team
- 2007-12-31
Who can join
Age: 18 and older, up to 18. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Patient Population
- Diagnosis of Schizophrenia as determine by the Structured Clinical Interview for DSM-IV
- No comorbid diagnosis of PTSD
- responders to quetiapine, determined by continuous treatment at the same dose of quetiapine and absence of psychiatric hospitalization for at least 3 months
- No history of drug dependency in their lifetime
- No history of alcohol or other substance abuse in the 6 months prior to entry into the study
- No history of head injury with loss of consciousness for more than 5 minutes
- No history of seizure disorder
- No mood stabilizing agents
- Between 18-65 and
- Able to sign informed consent
- Normal Controls
- Matched in age and gender to patient population
- No history of psychiatric dysfunction or alcohol or other substance dependence in their lifetime as determine by the SCID
- No history of alcohol or other substance abuse in the previous 6 months
- No family history of psychotic disorder in first degree relatives as assessed by the FH-RDC diagnostic interview
- No history of head injury with loss of consciousness for more than 5 minutes
- No history of seizure disorder
- Between 18-65
- Able to sign informed consent
You may not qualify if…
- Subjects will be excluded from participating in this study if they:
- Require treatment with a mood stabilizer
- Have had an inpatient hospitalization in the past 3 months
- Have a history of a neurological disorder
- Have any other axis I diagnosis besides schizophrenia
Where it is running
- New Mexico VA Healthcare System — Albuquerque, New Mexico, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.